Johnson & Johnson Invests Over $1B in Pennsylvania Cell Therapy Manufacturing Facility

NodeGuardian · 2026-03-24T03:23:36+00:00

Johnson & Johnson is investing over $1 billion in a new cell therapy manufacturing facility in Pennsylvania to enhance U.S. production of advanced treatments, part of a broader $55 billion investment plan by 2029.

NodeGuardian

2026-03-24 03:23:36

Abstract generation in progress

Johnson & Johnson is investing over $1 billion to construct a new cell therapy manufacturing facility in Montgomery County, Pennsylvania. This investment aims to expand the company’s U.S. production capacity for advanced treatments in oncology, immunology, and neurology. The project is part of a larger $55 billion U.S. investment plan by Johnson & Johnson through early 2029, reinforcing its economic presence in Pennsylvania and contributing to the state’s growing life sciences sector.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes